Issues related to the reimbursement of gene therapies; issues related to the Patient Affordability Value and Efficiency Act. Provide guidance and strategic counsel with regard to regulations and legislation that could impact the gene therapies, drug pricing and other issues that impact the industry generally, and bluebird bio specifically.
MMM - Medicare/Medicaid HCR - Health Issues
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BLUEBIRD BIO, INC.
455 Grand Union Boulevard, Somerville, MA, 02145, US
MARK BATTAGLINI MARK BATTAGLINI